A Win For TuHURA Biosciences, Inc.
Fri, Feb 06, 2026 at 07:29 PM
TuHURA Biosciences, Inc. (HURA:NASDAQ) shot up at $0.63, representing a gain of 43%. On Fri, Feb 06, 2026, HURA:NASDAQ touched a New 2-Week Intraday Low of $0.43. The stock got featured on our News Catalysts scanner on Mon, Feb 02, 2026 at 10:54 AM in the 'BIOTECH' category. From Mon, Jan 26, 2026, the stock recorded 11.11% Up Days and 20.00% Green Days
The stock spiked on Mon, Feb 02, 2026 at $0.75 with a volume of 20M+.
About TuHURA Biosciences, Inc. (HURA:NASDAQ)
Kintara Therapeutics Inc is engaged in the development of novel cancer therapies for patients with unmet medical needs.
Top 10 Gainers:
- SMX (Security Matters) Public Limited Company (SMX:NASDAQ), 89.58%
- Pulse Biosciences, Inc. (PLSE:NASDAQ), 51.57%
- CCH Holdings Ltd (CCHH:NASDAQ), 50.62%
- TuHURA Biosciences, Inc. (HURA:NASDAQ), 42.95%
- Jiuzi Holdings, Inc. (JZXN:NASDAQ), 42.74%
- Rail Vision Ltd. (RVSN:NASDAQ), 39.14%
- BILL Holdings, Inc. (BILL:NYSE), 37.16%
- Soluna Holdings, Inc. (SLNH:NASDAQ), 34.67%
- Bio Green Med Solution Inc. (BGMS:NASDAQ), 33.73%
- Datavault AI Inc. (DVLT:NASDAQ), 32.86%